While human and mouse resistin only share a 59% homology, and it currently appears there are differences in regulation and function, human resistin is involved in inflammation-induced insulin resistance in the liver and skeletal muscle and may also be implicated in cardiovascular disease [53], though the influence of obesity on resistin levels is unclear [54,55,56]. This evidence concerns the gene RETN and obesity disorder.